Institutional Biosafety Committee (IBC)
The New York University Institutional Biosafety Committee (IBC) is responsible for enforcing policies and guidelines relevant to the use of all potentially hazardous biological materials. The IBC is responsible for providing review and oversight to ensure that all forms of research involving recombinant DNA, infectious agents, non-human primate materials (including established cell lines), select agents, and human gene transfer studies conducted at New York University and within the NYU Langone Medical Center System are in compliance with the NIH Guidelines and all of the Institution's policies. The IBC is responsible for ensuring that research involving these agents is conducted in a manner that protects the researchers, laboratory workers, human research subjects, the public and the environment. The IBC is authorized to inspect research facilities, approve research practices and procedures, and to take actions, such as enforcement of cessation of research activities, in the event of an unsafe workplace situation. The NYU and NYUMC’s Office of Environmental Health and Safety (EH&S) supports the IBC in carrying out its mission.